
Organoid Sciences targets animal-free drug testing with ODISEI platform ahead of IPO
As the global pharmaceutical industry grapples with rising ethical concerns and regulatory changes around animal testing, Korean biotech Organoid Sciences is positioning itself to disrupt the status quo with its innovative organoid-based platform, ODISEI. …